The pharmaceutical industry is in a constant state of flux, led by a regular wave of consolidation and occasional spinoffs.

Soligenix Inc. hasn't claimed benefits from the Orphan Drug Tax Credit because the pre-revenue company has yet to generate taxable profits.

Jersey City Mayor Steven Fulop's sick-leave proposal — under which employers with more than 10 employees must allow both full and part-time workers to accrue five paid sick days a year — is causing a stir well before the measure goes before the city council Wednesday.

Morristown-based dosage solution company Capsugel announced Thursday it will acquire Oregon-based Bend Research.

Princeton-based advanced wound care company Derma Sciences announced Wednesday it has purchased 2.3 million newly issued common shares of New Zealand-based health and beauty company Comvita Limited for $7 million. The investment amounts to 7.3 percent of outstanding Comvita shares.

Parsippany-based Delta Dental of New Jersey announced Wednesday it named Dennis Wilson its new president and CEO. Wilson is replacing Walter VanBrunt, who is retiring after serving as CEO for the past 15 years.

Princeton-based specialty chemicals company Rockwood Holdings Inc. announced Wednesday it has completed its sale of German ceramics producer CeramTec to European private equity firm Cinven for € 1.49 billion ($1.96 billion).

C.R. Bard Inc. has agreed to acquire Rochester Medical Inc., a developer and supplier of silicone urinary incontinence and urine drainage products, for about $262 million, or $20 a share.

South Brunswick pharmaceutical company Tris Pharma has inked a licensing agreement to commercialize Karbinal ER, the first time-release drug that treats allergic rhinitis in children aged 2 and older.

Jersey City Mayor Steven Fulop's plan to make his city the first in New Jersey to require employers to provide paid sick days is drawing support from unions and advocacy groups, but opposition from business lobbyists — who are also fighting a bill in Trenton that would mandate paid sick time for all New Jersey workers.

Morris Plains-based Immunomedics Inc. announced Tuesday it has appointed a new vice president for finance and chief financial officer. Peter Pfreundschuh will take over for Gerard Gorman after a transition period.